Basit öğe kaydını göster

dc.contributor.authorSengelen, Aslihan
dc.contributor.authorOnay-Ucar, Evren
dc.contributor.authorKiyga, Ezgi
dc.contributor.authorMertoglu, Elif
dc.date.accessioned2022-02-18T10:47:45Z
dc.date.available2022-02-18T10:47:45Z
dc.identifier.citationMertoglu E., Sengelen A., Kiyga E., Onay-Ucar E., "Therapeutic Drugs and Natural Products: The Effect of Suppressing Heat Shock Proteins (Hsp) in Brain Tumors", HEAT SHOCK PROTEINS IN NEUROSCIENCE, cilt.20, ss.189-208, 2019
dc.identifier.issn1877-1246
dc.identifier.otherav_bd287d8a-837a-4b05-9462-1ee4411e2afb
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/179929
dc.identifier.urihttps://doi.org/10.1007/978-3-030-24285-5_12
dc.description.abstractBrain tumors are common in the population, and approximately 17,000 new patients are diagnosed every year. Although there are advancements in conventional treatment, including surgery, radiotherapy and chemotherapy, they have limited effectiveness for the patients with brain tumors. However, with recent developments of tumor biology, novel approaches discovering new agents or their combinations have been proposed. Heat shock proteins (HSP) serve as molecular chaperones and they play a prominent role in protein homeostasis. Expression level of HSP enhance under the stressful conditions and they protect the cells by assisting of protein folding. In addition, HSP have attracted a great interest as a potential anticancer target and the development of HSP inhibitors demonstrating treatment is promising for cancer. Several therapeutic drugs and natural products that target signaling pathways associated with HSP are being developed and the efficacy of these agents in brain tumors is investigated. Consequently, our chapter puts emphasis on application of HSP in the treatment of brain tumors and the potential of therapeutic drugs and/or natural products in these tumors. It is hoped that approaches discussed in this chapter will overcome the existing limitations in the treatment with brain tumors and lead to a better prognosis for the patients.
dc.language.isoeng
dc.subjectSitogenetik
dc.subjectTemel Bilimler
dc.subjectBiochemistry, Genetics and Molecular Biology (miscellaneous)
dc.subjectClinical Biochemistry
dc.subjectCancer Research
dc.subjectMolecular Biology
dc.subjectDevelopmental Neuroscience
dc.subjectDrug Discovery
dc.subjectAging
dc.subjectCellular and Molecular Neuroscience
dc.subjectCognitive Neuroscience
dc.subjectGeneral Biochemistry, Genetics and Molecular Biology
dc.subjectBiochemistry
dc.subjectGeneral Neuroscience
dc.subjectNeuroscience (miscellaneous)
dc.subjectSensory Systems
dc.subjectStructural Biology
dc.subjectHuman-Computer Interaction
dc.subjectPhysical Sciences
dc.subjectLife Sciences
dc.subjectBİYOKİMYA VE MOLEKÜLER BİYOLOJİ
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectYaşam Bilimleri
dc.subjectSinirbilim ve Davranış
dc.subjectNEUROSCIENCES
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectMoleküler Biyoloji ve Genetik
dc.titleTherapeutic Drugs and Natural Products: The Effect of Suppressing Heat Shock Proteins (Hsp) in Brain Tumors
dc.typeMakale
dc.relation.journalHEAT SHOCK PROTEINS IN NEUROSCIENCE
dc.contributor.departmentİstanbul Üniversitesi , Fen Fakültesi , Moleküler Biyoloji ve Genetik Bölümü
dc.identifier.volume20
dc.identifier.startpage189
dc.identifier.endpage208
dc.contributor.firstauthorID3386890


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster